"Meglumine iotroxate (BiliscopinTM) is an iodinated, intravenous contrast agent that is preferentially excreted into the biliary tree and is used in CT intravenous cholangiography."
"The typical dose is 100 mL Biliscopin (105 mg meglumine iotroxate/mL; 5.0 g iodine), which is administered via slow IV infusion (over 30-60 minutes) to optimise biliary concentration."
"pregnancy: safety has not been established; demonstrated to be embryotoxic in rabbits 3"
"Adverse reactions are uncommon (~2%; range 0.8-3.4%) with no fatal reactions recorded and severe reactions (e.g. anaphylaxis) rare. Common reactions include pruritus, rash, hives and nausea 1,2. Mild adverse reactions are more common if the patient is dehydrated, and the rate of infusion is rapid 7."
"Adverse reactions are uncommon (~2%; range 0.8-3.4%) with no fatal reactions recorded and severe reactions (e.g. anaphylaxis) rare. Common reactions include pruritus, rash, hives and nausea 1,2. Mild adverse reactions are more common if the patient is dehydrated, and the rate of infusion is rapid 7."